DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Breckenridge Pharmaceutical
04 2Bal Pharma
05 2ANGITA PHARMA INC.
06 6Accord healthcare
07 1Ananta Medicare
08 4Apotex Inc
09 2Auro Pharma Inc
10 2Aurobindo Pharma Limited
11 2Austell Laboratories
12 2BIOMED 2002 INC
13 2Bionpharma
14 2Bluepharma
15 37Bristol Myers Squibb
16 2Cipla Medpro South Africa
17 2Dr Reddy's Laboratories (Pty) Ltd
18 2Dr Seidel Life Science
19 1Eqova
20 1Evertogen
21 2Farmaprojects S.A.U
22 2Hetero Drugs
23 2INNOVATA PHARMACEUTICALS
24 2Impax Laboratories
25 2Indoco Remedies Limited
26 2Intas Pharmaceuticals
27 2JAMP PHARMA
28 2LABORATOIRE RIVA INC.
29 2Laboratorio Eczane Pharma
30 2MANTRA PHARMA INC
31 2MARCAN PHARMACEUTICALS INC
32 2MINT PHARMACEUTICALS INC
33 2Macleods Pharmaceuticals Limited
34 2Medichem S.A
35 2Micro Labs Limited
36 2Natco Pharma (Canada) Inc
37 4Nora Pharma
38 2PRO DOC LIMITEE
39 2Pfizer Inc
40 1Prinston
41 5Pulse Pharmaceuticals
42 2SANIS HEALTH INC
43 2SIVEM PHARMACEUTICALS ULC
44 4Sandoz B2B
45 1ScieGen Pharmaceuticals
46 2Sigmapharm Laboratories, LLC
47 1Stivaph Healthcare
48 6Sun Pharmaceutical Industries Limited
49 2Sunshine Lake Pharma
50 2Tecnimede
51 3Teva Pharmaceutical Industries
52 2Titan Laboratories
53 4Torrent Pharmaceuticals Limited
54 2Viatris
55 2Wanbang Biopharmaceuticals
56 2Zentiva
57 1Zhejiang Yongning Pharmaceutical Co., Lt
58 2Zydus Lifesciences
59 2Zydus Pharmaceuticals
01 11Antic-calc Tablet, Film Coated
02 1Apixaban 2,5Mg 10 Units Oral Use
03 1Apixaban 2,5Mg 20 Joined' Oral Use
04 1Apixaban 2,5Mg 60 Units Oral Use
05 1Apixaban 5Mg 28 Combined Oral Use
06 1Apixaban 5Mg 60 Units Oral Use
07 2Coated Tablet
08 14FCT
09 2FILM COATED PILL
10 10Film Coated Tablet
11 2Film Coated Tablet
12 7Film-Coated Tablets
13 2Oral Solid Dosage Form
14 4TAB
15 40TABLET
16 6TABLET; ORAL
17 33TABLET;ORAL
18 21Tablet
19 2Tablets
20 3tablet
21 5Blank
01 14DISCN
02 4EU Dossier Readiness-Q4 2018
03 16Generic
04 2Lead Market Dossiers- Filed
05 2Originator
06 40Prescription
07 14RX
08 77Blank
01 2ACH-APIXABAN
02 2AG-APIXABAN
03 41APIXABAN
04 1APIXABAN 2,5 DRL
05 1APIXABAN 5 DRL
06 2APO-APIXABAN
07 2AURO-APIXABAN
08 3Apixaban
09 1Apixaban 2,5 Accord
10 1Apixaban 5 Accord
11 2BIO-APIXABAN
12 1Deksel CD
13 6ELIQUIS
14 1EPLIPIX 2,5
15 1EPLIPIX 5
16 5Eliqs
17 26Eliquis
18 1Eliquis 2.5 mg
19 1Eliquis 5 mg
20 2Emboxan
21 1Fibranix 2,5
22 1Fibranix 5
23 1INNOKLOD 2,5
24 1INNOKLOD 5
25 2JAMP APIXABAN
26 2M-APIXABAN
27 2MAR-APIXABAN
28 2MINT-APIXABAN
29 2NAT-APIXABAN
30 2NRA-APIXABAN
31 2NRA-APIXABAN TABLETS
32 1PIXECLOT 2.5 mg
33 1PIXECLOT 5 mg
34 2PRO-APIXABAN
35 2RIVA APIXABAN
36 2SANDOZ APIXABAN SDZ
37 2TARO-APIXABAN
38 2TEVA-APIXABAN
39 2Thromboxan
40 2Xanza
41 1Xarpix 2,5
42 1Xarpix 5
43 1Zyquis 2.5
44 1Zyquis 5
45 29Blank
01 2Argentina
02 8Australia
03 40Canada
04 2China
05 2Czech Republic
06 6Germany
07 19India
08 5Italy
09 11Norway
10 4Portugal
11 18South Africa
12 4Spain
13 2Sweden
14 7Switzerland
15 39USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET; ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 210082
Regulatory Info :
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2019-12-23
Application Number : 210013
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.GMG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
